60
Participants
Start Date
January 31, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
June 30, 2009
danazol
danazol applied topically once per day for 4 treatment cycles
Placebo
placebo topically applied once daily for 4 treatment cycles
Rochester Clinical Research, Inc., Rochester
James A Simon, M.D., PC, Washington D.C.
Virginia Women's Center, Richmond
Atlanta North Gynecology, PC, Roswell
Southeastern Integrated Medical, LLC, Gainsville
Palm Beach Research Center, West Palm Beach
Visions Clinical Research, Boynton Beach
Southeastern Clinical Research, Chattanooga
Jackson Clinic, Jackson
Kentucky Medical Research Center, Lexington
Columbus Center for Women's Health Research, Columbus
Physician's Research Group, Indianapolis
Center for Women's Research, Chicago
Women's Health Practice, Champaign
Clinical Trials of Texas, Inc., San Antonio
Seven Oaks Women's Center, San Antonio
Horizons Clinical Research Center, LLC, Denver
Salt Lake Research, Salt Lake City
Women's Health Research, Phoenix
Advanced Clinical Therapeutics, LLC, Tucson
Impact Clinical Trials, Las Vegas
Impact Clinical Trials, Beverly Hills
Women's Health Care at Frost Street, San Diego
Women's Clinical Research Center, Seattle
MedVadis Research Corporation, Wellesley Hills
Delaware Valley OB/GYN and Infertility Group, PC, Lawrenceville
Phoenix OB-GYN Associates, Moorestown
UMDNJ Robert Wood Johnson Medica School Women's Health Institute, New Brunswick
Analgesic Development, Ltd., New York
Drexel University College of Medicine, Philadelphia
FemmePharma Global Healthcare, Inc.
INDUSTRY